This is a double-blind, placebo-controlled trial of 120 binge-drinking MSM to 12 weeks of naltrexone 50mg, to be taken in anticipation of heavy drinking. Ethnically and racially diverse participants will be recruited using Respondent Driven Sampling as well as active field recruitment. MSM will be seen weekly for alcohol-metabolite urine testing, study drug dispensing, and brief counseling for alcohol use. Safety assessments and behavioral surveys will be completed monthly.
Age range
18 Years – 70 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Binge Drinking Days Per Week
Timeframe: 12 weeks
Positive Ethyl Glucuronide (EtG) Tests
Timeframe: 12 weeks
Male Anal Sex Partners
Timeframe: 12 weeks
Unprotected Anal Sex Partners While Intoxicated With Alcohol
Timeframe: 12 weeks
HIV-serodiscordant Unprotected Anal Sex Partners
Timeframe: 12 weeks
Unprotected Anal Sex Events With Serodiscordant Partners
Timeframe: 12 weeks